MIP Pharma GmbH
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- OMEPRAZOLE GRINDEKS gastro-resistant capsule, hard 20 mg
- A06 - Agentes contra el estreñimiento
- GASTROBIOL oral gel 650 mg/ml
- OLOPEG powder for oral solution
- J01 - Antibacterianos para uso sistémico
- AMOXICILLIN MIP powder for oral suspension 50 mg/ml
- AMOXICILLIN MIP tablet 1 000 mg
- AMOXICILLIN MIP tablet 500 mg
- CEFAZOLIN MIP powder for solution for injection 2 g
- CEFEPIME MIP powder for solution for injection 1 g
- CEFEPIME MIP powder for solution for injection 2 g
- CEFOTAXIME MIP powder for solution for injection 1 g
- CEFOTAXIME MIP powder for solution for injection 2 g
- CEFTAZIDIME MIP powder for solution for injection 1 g
- CEFTAZIDIME MIP powder for solution for injection 2 g
- CEFTRIAXONE MIP powder for solution for infusion 2 g
- CEFTRIAXONE MIP powder for solution for injection 1 g
- CEFUROXIME MIP powder for solution for injection 1 500 mg
- CEFUROXIME MIP powder for solution for injection 750 mg
- CLINDAMYCIN-MIP film-coated tablet 300 mg
- CLINDAMYCIN-MIP film-coated tablet 600 mg
- CLINDAMYCIN-MIP solution for injection 150 mg/ml
- VANCOSAN powder for solution for infusion 1 g
- VANCOSAN powder for solution for infusion 500 mg